CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Roll-In Cohort: Single Application of N-SWEAT Patch +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04599907
NCT04599907N/ACompleted
CompareCT.gov

An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

Candesant Biomedical, Inc.·interventional·Posted Oct 23, 2020·Updated Sep 7, 2023

In Brief

A clinical study evaluating Roll-In Cohort: Single Application of N-SWEAT Patch, Randomized Cohort: Single Application of N-SWEAT Patch, and 1 other intervention for Primary Axillary Hyperhidrosis. Completed, enrolled 120 participants across 9 sites.

Detailed Summary

The Sahara Study is a study to evaluate the safety and effectiveness of the N-SWEAT Patch for use in subjects with excessive axillary sweating, or primary focal axillary hyperhidrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Axillary Hyperhidrosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 23, 2020
Enrollment StartOct 13, 2020
Primary CompletionJul 6, 2021
Study CompletionDec 20, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.7 years ago

Interventions

Roll-In Cohort: Single Application of N-SWEAT Patchdevice

Single Application of N-SWEAT Patch in both axillae for 10 subjects

Randomized Cohort: Single Application of N-SWEAT Patchdevice

Single Application of N-SWEAT Patch in both axillae for subjects randomized to the treatment group

Randomized Cohort: Single Application of Sham Patchdevice

Single Application of Sham Patch in both axillae for subjects randomized to the control group